
Ignite Proteomics Launches 10,000-Patient Oncology Registry to Study Functional Proteomics in Cancer Therapy Selection
Ignite Proteomics Launches Prospective 10,000-Patient Oncology Registry to Assess Functional Proteomics in Cancer Therapy Selection Ignite Proteomics, LLC (“Ignite Proteomics”), a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), has announced the…












